Search - tctmd.com

Displaying 1 - 18 of 18

Sort: Relevancy | Date

News Daily News

No Clarity on Colchicine: Two Meta-analyses Spark Debate on Drug’s Merits

Michael O'Riordan

July 14, 2025

News Daily News

Bempedoic Acid Reassures in Patients With and Without Diabetes: CLEAR Outcomes

Michael O'Riordan

December 08, 2023

News Daily News

SELECT: Semaglutide Cuts CV Events in Adults With Overweight or Obesity

Todd Neale

August 08, 2023

News Daily News

FDA Approves Colchicine for Decreasing CV Events

Caitlin E. Cox

June 20, 2023

News Daily News

Acute MI, Stroke Risks Rise in the Months After Gout Flares

Todd Neale

August 02, 2022

News Daily News

Colchicine Lowers CVD Risk No Matter When Past ACS Occurred: LoDoCo2

Michael O'Riordan

August 26, 2021

News Daily News

Meta-analysis Affirms Colchicine’s Myriad CV Benefits

Caitlin E. Cox

April 12, 2021

News Daily News

Colchicine in the Crosshairs for Its High US Cost

Caitlin E. Cox

December 01, 2020

News Daily News

Bempedoic Acid Safe, Lowers LDL in Hypercholesterolemia: Pooled RCT Data

Yael L. Maxwell

July 07, 2020

News Daily News

Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019

Yael L. Maxwell

December 20, 2019

News Daily News TCT 2019

BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On

L.A. McKeown

October 02, 2019

News Daily News

Bempedoic Acid Boosts LDL Cholesterol-Lowering in Statin-Treated CVD Patients: CLEAR Harmony

Michael O'Riordan

March 15, 2019

News Daily News

FDA Adds Boxed Warning About CV Risks to Gout Drug Febuxostat

Shelley Wood

February 22, 2019

Febuxostat Emerges Relatively Unscathed After FDA Advisory Committee Vote

News Daily News

Febuxostat Emerges Relatively Unscathed After FDA Advisory Committee Review

Caitlin E. Cox

January 11, 2019

News Daily News

All-Cause Death Not Increased With Febuxostat Among Medicare Patients With Gout

Caitlin E. Cox

June 19, 2018

News Daily News

Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests

Michael O'Riordan

October 20, 2017

News Daily News

Memo for Meta-analyses: Put Quality Over Quantity, Says AHA

Caitlin E. Cox

August 11, 2017

News Daily News

Colchicine Reduces BMS Restenosis in Diabetic Patients

April 19, 2013

Advertisement

No Clarity on Colchicine: Two Meta-analyses Spark Debate on Drug’s Merits

Bempedoic Acid Reassures in Patients With and Without Diabetes: CLEAR Outcomes

SELECT: Semaglutide Cuts CV Events in Adults With Overweight or Obesity

FDA Approves Colchicine for Decreasing CV Events

Acute MI, Stroke Risks Rise in the Months After Gout Flares

Colchicine Lowers CVD Risk No Matter When Past ACS Occurred: LoDoCo2

Meta-analysis Affirms Colchicine’s Myriad CV Benefits

Colchicine in the Crosshairs for Its High US Cost

Bempedoic Acid Safe, Lowers LDL in Hypercholesterolemia: Pooled RCT Data

Year in Review: New Guidelines, Inclisiran, Dapagliflozin Impact CVD Prevention in 2019

BLADE-PCI: Antirestenotic Drug Flops in Diabetics, but Inflammation Hypothesis Lives On

Bempedoic Acid Boosts LDL Cholesterol-Lowering in Statin-Treated CVD Patients: CLEAR Harmony

FDA Adds Boxed Warning About CV Risks to Gout Drug Febuxostat

Febuxostat Emerges Relatively Unscathed After FDA Advisory Committee Review

All-Cause Death Not Increased With Febuxostat Among Medicare Patients With Gout

Colchicine Stabilizes Plaque in ACS Patients, Imaging Study Suggests

Memo for Meta-analyses: Put Quality Over Quantity, Says AHA

Colchicine Reduces BMS Restenosis in Diabetic Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content